Last $1.19 USD
Change Today -0.01 / -0.83%
Volume 392.3K
ARQL On Other Exchanges
Symbol
Exchange
NASDAQ GM
Frankfurt
As of 8:10 PM 12/19/14 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for arqule inc (ARQL)

Year over year, ArQule Inc. has seen revenues fall from $36.4M USD to $15.9M USD. This along with an increase in the cost of goods sold expense has led to a reduction in the bottom line from a loss of $10.9M USD to an even larger loss of $24.6M USD.
Currency in
Millions of US Dollars
As of:Dec 31
2010
Reclassified
Dec 31
2011
Reclassified
Dec 31
2012
Reclassified
Dec 31
2013
4 Year
Trend
Revenues29.247.336.415.9
TOTAL REVENUES29.247.336.415.9
Cost of Goods Sold44.245.034.027.6
GROSS PROFIT-14.92.32.4-11.6
Selling General & Admin Expenses, Total16.313.413.912.8
OTHER OPERATING EXPENSES, TOTAL16.313.413.912.8
OPERATING INCOME-31.3-11.1-11.4-24.5
Interest Expense-0.30.00.00.0
Interest and Investment Income0.60.30.40.5
NET INTEREST EXPENSE0.30.30.40.5
Other Non-Operating Income (Expenses)1.0------
EBT, EXCLUDING UNUSUAL ITEMS-30.0-10.8-11.0-24.0
Merger & Restructuring Charges-------0.6
Gain (Loss) on Sale of Investments-0.70.00.10.1
EBT, INCLUDING UNUSUAL ITEMS-30.7-10.8-10.9-24.6
Income Tax Expense-0.5------
Earnings from Continuing Operations-30.1-10.8-10.9-24.6
NET INCOME-30.1-10.8-10.9-24.6
NET INCOME TO COMMON INCLUDING EXTRA ITEMS-30.1-10.8-10.9-24.6
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS-30.1-10.8-10.9-24.6
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ARQL:US $1.19 USD -0.01

ARQL Competitors

Market data is delayed at least 15 minutes.

Company Last Change
AVEO Pharmaceuticals Inc $0.85 USD +0.04
CrystalGenomics Inc 11,500 KRW +250.00
Curis Inc $1.17 USD +0.02
Exelixis Inc $1.33 USD -0.02
Rigel Pharmaceuticals Inc $2.44 USD +0.09
View Industry Companies
 

Industry Analysis

ARQL

Industry Average

Valuation ARQL Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 7.2x
Price/Book 1.7x
Price/Cash Flow NM Not Meaningful
TEV/Sales 1.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ARQULE INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.